NCT04434664View on ClinicalTrials.gov

BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 3, 2024

Study Completion Date

December 20, 2024

Conditions
Heart Failure with Preserved Ejection FractionHypertension
Interventions
DRUG

Amlodipine Besylate

The interventions will be implemented in random order in a crossover (AB-BA) design, separated by an approximately one-week washout period

DRUG

Metoprolol Succinate

The interventions will be implemented in random order in a crossover (AB-BA) design, separated by an approximately one-week washout period

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Julio Chirinos, MD, PhD

UNKNOWN

collaborator

Raymond Townsend, MD

UNKNOWN

lead

University of Pennsylvania

OTHER

NCT04434664 - BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF | Biotech Hunter | Biotech Hunter